Literature DB >> 29661416

Anaemia and red blood cell transfusion in intracranial neurosurgery: a comprehensive review.

A Kisilevsky1, A W Gelb2, M Bustillo3, A M Flexman4.   

Abstract

Both anaemia and blood transfusion are associated with poor outcomes in the neurosurgical population. Based on the available literature, the optimal haemoglobin concentration for neurologically injured patients appears to be in the range of 9.0-10.0 g dl-1, although the individual risks and benefits should be weighed. Several perioperative blood conservation strategies have been used successfully in neurosurgery, including correction of anaemia and coagulopathy, use of antifibrinolytics, and intraoperative cell salvage. Avoidance of non-steroidal anti-inflammatory drugs and starch-containing solutions is recommended given the potential for platelet dysfunction.
Copyright © 2017 British Journal of Anaesthesia. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  anaemia; coagulation; neurosurgery; transfusion

Mesh:

Year:  2018        PMID: 29661416     DOI: 10.1016/j.bja.2017.11.108

Source DB:  PubMed          Journal:  Br J Anaesth        ISSN: 0007-0912            Impact factor:   9.166


  3 in total

1.  The Effect of Antifibrinolytic Use on Intraoperative Cell Salvage: Results from a National Registry of Surgical Procedures.

Authors:  Alfred H Stammers; Eric A Tesdahl; Linda B Mongero; Kirti Patel
Journal:  J Extra Corpor Technol       Date:  2020-09

2.  Economic impact of a machine learning-based strategy for preparation of blood products in brain tumor surgery.

Authors:  Thara Tunthanathip; Sakchai Sae-Heng; Thakul Oearsakul; Anukoon Kaewborisutsakul; Chin Taweesomboonyat
Journal:  PLoS One       Date:  2022-07-01       Impact factor: 3.752

3.  Efficacy of Intraoperative Blood Salvage in Cerebral Aneurysm Surgery.

Authors:  Bedjan Behmanesh; Florian Gessler; Elisabeth Adam; Ulrich Strouhal; Sae-Yeon Won; Daniel Dubinski; Volker Seifert; Juergen Konczalla; Christian Senft
Journal:  J Clin Med       Date:  2021-12-07       Impact factor: 4.241

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.